Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of Blood and Marrow Transplantation

No standard exists for the treatment of myelodysplastic syndrome relapsing after allogeneic stem cell transplantation. We performed a retrospective registry analysis of outcomes and risk factors in 698 patients, treated with different strategies. The median overall survival from relapse was 4.7 mont...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmid, Christoph, de Wreede, Liesbeth C., van Biezen, Anja, Finke, Jürgen, Ehninger, Gerhard, Ganser, Arnold, Volin, Liisa, Niederwieser, Dietger, Beelen, Dietrich, Alessandrino, Paolo, Kanz, Lothar, Schleuning, Michael, Passweg, Jakob, Veelken, Hendrik, Maertens, Johan, Cornelissen, Jan J., Blaise, Didier, Gramatzki, Martin, Milpied, Noel, Yakoub-Agha, Ibrahim, Mufti, Ghulam, Rovira, Montserrat, Arnold, Renate, de Witte, Theo, Robin, Marie, Kröger, Nikolaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792268/
https://www.ncbi.nlm.nih.gov/pubmed/29101205
http://dx.doi.org/10.3324/haematol.2017.168716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792268/
https://www.ncbi.nlm.nih.gov/pubmed/29101205
http://dx.doi.org/10.3324/haematol.2017.168716

Ejemplares similares